Form 4 for ABEO ABEONA THERAPEUTICS INC.
Accepted 2025-01-23 00:00:00 ET · period of report 2025-01-21 · accession 0001493152-25-003463 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-23 | 2025-01-21 | ABEO | Seshadri Vishwas | CEO, Dir | A - Grant | $0.00 | +476.4K | 1.38M | +53% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-21 | A | A | 476,435 | $0.00 | 1,380,322 | D | — | — | (F1) The restricted stock will vest one-third on each of January 21, 2026, January 21, 2027 and January 21, 2028. |